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Stakeholder involvement in systematic
reviews: a scoping review
Alex Pollock1* , Pauline Campbell1, Caroline Struthers2, Anneliese Synnot3,4, Jack Nunn5, Sophie Hill3,
Heather Goodare6, Jacqui Morris7, Chris Watts8 and Richard Morley9
Abstract
Background: There is increasing recognition that it is good practice to involve stakeholders (meaning patients, the
public, health professionals and others) in systematic reviews, but limited evidence about how best to do this. We
aimed to document the evidence-base relating to stakeholder involvement in systematic reviews and to use this
evidence to describe how stakeholders have been involved in systematic reviews.
Methods: We carried out a scoping review, following a published protocol. We searched multiple electronic
databases (2010–2016), using a stepwise searching approach, supplemented with hand searching. Two authors
independently screened and discussed the first 500 abstracts and, after clarifying selection criteria, screened a
further 500. Agreement on screening decisions was 97%, so screening was done by one reviewer only. Pre-planned
data extraction was completed, and the comprehensiveness of the description of methods of involvement judged.
Additional data extraction was completed for papers judged to have most comprehensive descriptions. Three
stakeholder representatives were co-authors for this systematic review.
Results: We included 291 papers in which stakeholders were involved in a systematic review. Thirty percent
involved patients and/or carers. Thirty-two percent were from the USA, 26% from the UK and 10% from Canada.
Ten percent (32 reviews) were judged to provide a comprehensive description of methods of involving
stakeholders. Sixty-nine percent (22/32) personally invited people to be involved; 22% (7/32) advertised
opportunities to the general population. Eighty-one percent (26/32) had between 1 and 20 face-to-face meetings,
with 83% of these holding ≤ 4 meetings. Meetings lasted 1 h to ½ day. Nineteen percent (6/32) used a Delphi
method, most often involving three electronic rounds. Details of ethical approval were reported by 10/32. Expenses
were reported to be paid to people involved in 8/32 systematic reviews.
Discussion/conclusion: We identified a relatively large number (291) of papers reporting stakeholder involvement
in systematic reviews, but the quality of reporting was generally very poor. Information from a subset of papers
judged to provide the best descriptions of stakeholder involvement in systematic reviews provide examples of
different ways in which stakeholders have been involved in systematic reviews. These examples arguably currently
provide the best available information to inform and guide decisions around the planning of stakeholder
involvement within future systematic reviews. This evidence has been used to develop online learning resources.
Systematic review registration: The protocol for this systematic review was published on 21 April 2017.
Publication reference: Pollock A, Campbell P, Struthers C, Synnot A, Nunn J, Hill S, Goodare H, Watts C, Morley R:
Stakeholder involvement in systematic reviews: a protocol for a systematic review of methods, outcomes and
effects. Research Involvement and Engagement 2017, 3:9. https://doi.org/10.1186/s40900-017-0060-4.
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Background
The concept of active involvement in research of people
with a healthcare condition, their families, friends and
carers, was founded on the principle that people affected
by the condition have a moral right to contribute to de-
cisions about what research is undertaken and in what
way [1–3]. The active involvement of other stakeholders
(meaning patients, the public, health professionals,
health decision makers and funders) grew from a desire
to address the lack of real-world relevance of research
and to ensure more effective implementation of research
findings into practice [4, 5]. It is now widely accepted in
many parts of the world that the active involvement of
many of these groups (that we collectively refer to as
‘stakeholders’) is beneficial to the quality, relevance and
impact of health research [2, 3]. Accordingly, many
funding bodies, including government and charities, now
mandate that researchers actively involve patients and
the public in their research, including systematic reviews
[6–9], although there is evidence of international vari-
ation in the extent to which patients and the public are
involved [10].
Systematic reviews aim to inform and support the de-
livery of evidence-based practice, by finding and bringing
together, in an explicit and transparent way, all the re-
search evidence that addresses a particular topic or
healthcare question. Stakeholder involvement within sys-
tematic reviews has been proposed as a way to enhance
the actual and perceived usefulness of synthesised re-
search evidence, addressing barriers to the uptake of evi-
dence into practice [11]. In this paper, we define (based
on a number of published definitions, e.g. [1, 12, 13])
‘active stakeholder involvement’ as the contribution of
people who are not researchers throughout the process
of production and dissemination of a systemic review,
including the planning and conduct of an individual sys-
tematic review. While there are a number of examples of
active stakeholder involvement in systematic reviews,
the approaches to, and extent of, involvement have var-
ied considerably [14–16] and synthesised evidence and
resources to guide practice is lacking. As well as active
involvement within individual systematic reviews, stake-
holders may also get involved at the level of organisa-
tions which commission or carry out systematic reviews.
A recent review explored examples of consumer involve-
ment within organisations (such as Cochrane) that sup-
port production of systematic reviews [17], but evidence
relating to relevant activities and roles of individual re-
searchers and how they may involve stakeholders in
their reviews remains scant [18].
As part of a wider project to provide guidance to re-
searchers about how to involve stakeholders in system-
atic reviews [19], we undertook a mixed-method
evidence synthesis, first completing a scoping review to
create a broad map of evidence relating to stakeholder
involvement in systematic reviews, followed by two con-
tingent syntheses [20]. Here, we report the results of the
scoping review. The aims of this paper are therefore to:
1. Document the evidence-base relating to stakeholder
involvement in systematic reviews
2. Use this evidence to describe key features of how
stakeholders have been involved in systematic
reviews
Methods
Design
We carried out a scoping review, following a protocol
[20]. We followed the methodological steps outlined by
Arksey and O’Malley [21] and used an iterative team ap-
proach, with regular team meetings to discuss progress
and reach consensus on next steps, to ensure clarity of
purpose and balance between breadth and comprehen-
siveness of the review [21–23]. Protocol deviations, with
justifications, are described in Additional file 1.
Search strategy
We implemented a stepwise approach [24] to promote
efficient identification of up-to-date literature, balancing
the expected large volume of literature with available
time and resources. Details of this approach, including
pre-agreed criteria and contingencies to inform decisions
relating to the extent of the searches, have previously
been described [20]; below we report the actual steps of
searching and brief justification for these steps.
We used a comprehensive search strategy, adapted for
each database (see Additional file 2). In step 1, we
searched a comprehensive set of databases (CENTRAL
(CDSR, DARE, HTA, Cochrane Methodology Register),
Embase (Ovid), MEDLINE (Ovid), CINAHL (EBSCO),
AMED, Joanna Briggs Database and ProQuest Disserta-
tions and Theses (handsearched)), within a narrow time
period (from 01 January 2014 to 09 April 2016). The
aim of step 1 was to, in an efficient way, identify the da-
tabases most likely to include relevant papers. In step 2,
we searched a more limited set of databases (Embase,
MEDLINE, CINAHL and HTA) for a longer time period
(01 January 2010 to 31 December 2013) with the aim of
exploring whether there was justification for extending
the search beyond 2010.
Searching and application of inclusion criteria was ap-
plied to each step prior to progression to the next step.
For step 1, we noted the source database (or databases)
of each identified record, and the databases from which
the greatest number of included papers were identified.
The results of these explorations were discussed and re-
view team consensus reached on which databases to in-
clude in step 2. After step 2, the review team explored
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the publication dates of records meeting our inclusion
criteria. The majority of papers meeting our inclusion
criteria (63%) were published in either 2014 or 2015 (see
Additional file 3). The sharp drop in numbers of in-
cluded papers from 2014 to 2013 and relatively stable
number of included papers between 2013 and 2010 were
key factors in the team decision not to extend electronic
searching to before 2010.
Additional sources we searched include the reference
lists of recent relevant reports and reviews (e.g. [6, 17,
25]), the reference lists of all included studies and arti-
cles published in the journal Research Involvement and
Engagement. To identify unpublished reports, we con-
tacted authors of published papers and promoted this
review via social media.
Selection criteria
Selection criteria for inclusion were purposefully wide.
We included any paper, published or unpublished, re-
gardless of study design, including commentaries, letters
and expert opinion, which investigated, reported or dis-
cussed any aspect of stakeholder involvement in a sys-
tematic review. We anticipated that we would include
(but would not be limited to) evidence such as published
systematic reviews which reported involvement; reports
of methods of involvement in an individual systematic
review; studies quantitatively or qualitatively evaluating
involvement in individual systematic reviews; and opin-
ions, commentary and discussion relating to involve-
ment in systematic reviews.
We excluded papers that focussed on stakeholder in-
volvement in the generation of research priorities (unless
they were specifically generating questions for a system-
atic review) and in both research more broadly, and
guideline development, unless there was an explicit
mention of involvement in systematic reviews. System-
atic reviews that focussed on synthesising the evidence
related to stakeholder involvement in primary research
were also excluded. We excluded titles without abstracts
and review protocols; this was a pragmatic decision
made in light of the high volume of search results.
Definition of key terms
We used the following operational definitions, pre-stated
in the protocol [20], to support the application of the se-
lection criteria:
 Stakeholder—any person who would be a knowledge
user of research but whose primary role is not
directly in research. Potential stakeholders include a
broad range of people, including those who are
actual or potential recipients of health or social care,
where this may include patients, carers and family
members, or people interested in remaining healthy
who are seeking information about a health
condition or treatment for personal use [26];
members of organisations that represent people who
use services; people with a professional role in
health and social care; policy makers and managers.
We documented the types of people involved within
any evidence included in this review, highlighting
where this included patients, carers and family
members, and where this included other
stakeholders only.
 Systematic review—a research process in which
literature relevant to a stated question is identified
and brought together (synthesised) using explicit
methods [27], including reporting of inclusion/
exclusion criteria, search methods and details of
included studies. We accepted systematic reviews
regardless of the type of evidence synthesised (i.e.
quantitative, qualitative, mixed-methods) and the
type of question addressed (e.g. intervention effect-
iveness, diagnostic test accuracy, patient
experiences).
 Involvement in a systematic review—any role or
contribution of stakeholders toward the development
of a review protocol, completion of any of the stages
of a systematic review or dissemination of the
findings of a review.
Methods of applying selection criteria
One review author (PC) ran the search strategy and ex-
cluded any obviously irrelevant titles. Two reviewers
(PC, AP) independently reviewed the abstracts and ap-
plied selection criteria to the first 500 records; agree-
ment was explored and a full team discussion held to
clarify the selection criteria. This clarification led to a
number of post hoc exclusion criteria (described above
under selection criteria and within Additional file 1).
Subsequently, we agreed that two independent review
authors (PC, AP) should review a further 500 records
using the clarified criteria and that if agreement between
independent reviewers was greater than 95% when using
these refined criteria, then subsequent selection of pa-
pers would be performed by one reviewer only; this
agreement was 97%, and therefore, one reviewer (AP)
screened the remaining abstracts. The full papers from
abstracts included after the screening process were con-
sidered at the data extraction and judgement stages (see
below); if a paper was found not to meet the inclusion
criteria at this stage, it was excluded.
Data extraction and synthesis
Data extraction
For all included papers, one reviewer (AP) extracted and
categorised data into structured tables. Extracted data
included bibliographic information, type of paper, stated
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aim, topic/focus of systematic review, study/review
methodology, description of reported involvement, de-
tails of people involved, stage in review process at which
people involved and any formal research methods used.
Retrospective categorisation of data included focus of re-
view and type of evidence synthesised (see Add-
itional file 1, protocol deviations). Details of the
operationalisation of these data extraction items are pro-
vided in Additional file 4.
Judgement of comprehensiveness of description
Our review aim was to describe key features of how
stakeholders have been involved in systematic reviews;
consequently, we were principally concerned with the
comprehensiveness of the description of methods of in-
volvement, rather than appraising the quality of the
methods of the reviews. We devised a method for judg-
ing the comprehensiveness of the description of the
method or approach to involvement, given that there are
no standardised tools for such a task. Criteria for cate-
gorising the comprehensiveness of the description pro-
vided within papers were developed, adapted from
Pollock [28]. Initially, two reviewers (AP, CS) assigned
these criteria independently for a random sample of 20%
of papers identified from step 1 of searching; this was 42
of 210 papers. There was agreement between independ-
ent reviewers for 57% (24/42) of the assessed sample.
The agreement between reviewers, implications relating
to disagreements and perceived risk of bias to the review
results are reported in Additional file 5. Following dis-
cussion and clarification of criteria (see Additional file 5),
it was agreed that one reviewer would assign judgements
to the remaining papers, using the following criteria:
 ‘Green’—comprehensive description of one (or
more) specific method or approach to the
involvement of stakeholders in systematic reviews.
Description sufficient to enable replication of
methods
 ‘Amber’—a brief or partial description of one (or
more) specific method or approach to the
involvement of stakeholders in systematic reviews.
Description sufficient to enable partial replication of
methods
 ‘Red’—few details provided and/or inadequate
description of the method or approach of
involvement of stakeholders in systematic reviews.
Description insufficient to enable any replication of
methods
Detailed description of methods or approaches to
involvement
Additional, more detailed, data extraction was per-
formed for papers that were judged as ‘green’ for
comprehensiveness of description. In addition to a nar-
rative description of the methods or approaches to in-
volvement, one reviewer (AP) extracted and tabulated
the stated aim of involvement, number and characteris-
tics of people involved, methods of recruitment, format
of involvement (e.g. face-to-face meeting, telephone
meeting, written consultation, online survey), amount of
involvement (number of meetings, number of days in-
volved), details of ethical approval and financial compen-
sation given to stakeholders, evaluation of the
involvement and tools used for reporting involvement.
Stakeholder involvement in this systematic review
One consumer (HG) and two consumer representatives
(RM, CS) were members of the project and author team
for this systematic review. All contributed to face-to-face
discussions which led to the development of the review
protocol, and read, commented on and had authorship
of the published protocol. All contributed to project
teleconferences throughout the review, particularly when
making decisions relating to the stepwise search
methods. Additionally, CS independently applied judge-
ments of comprehensiveness to a sample of full papers.
All three discussed the key findings of this review and
contributed as authors to the final manuscript.
Results
Results of the search
We screened 12,908 titles and abstracts and applied se-
lection criteria to 672 full papers. Three hundred
sixty-nine of these 672 full papers were excluded: 118 as
they were abstracts only, 18 as they were protocols, 16
as they were duplicates and 217 as they did not meet
our inclusion criteria. Reasons that these 217 did not
meet our inclusion criteria are listed in table of excluded
studies (Additional file 6); main reasons for exclusion
were that the paper was a systematic review but there
was no involvement of people (approximately 30%), the
paper did not describe or report a systematic review (ap-
proximately 25%) or the paper described involvement in
research other than a systematic review (approximately
25%). This left 291 papers that met our criteria for inclu-
sion in the scoping review (see Fig. 1).
Characteristics of included papers
Details of the 291 included papers are provided in the
table of included studies (Additional file 7). A brief sum-
mary is described below.
Type of paper
Thirty-one percent of included papers were published
systematic reviews; 54% were reports of a guideline or
recommendation in which a systematic review compo-
nent was described; and 5% were papers specifically
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describing methods of involving stakeholders in a sys-
tematic review.
Stakeholders involved
Thirty percent of the included papers involved patients
and/or carers within the systematic review process, while
41% involved other stakeholders (e.g. health profes-
sionals, academic experts, representatives of patient or-
ganisations) but not patients or their family members. In
almost one third of the included papers (29%), it was not
clear who the stakeholders involved in the review were
and whether this included patients and/or carers.
Country
One third (31.6%) of papers were from the USA, one
quarter (26.1%) from the UK and 10.0% from Canada.
Of the remaining papers, 22.7% were from Australia,
Netherlands, Germany, Italy, France or Spain, and 9.6%
from a further 15 countries with between 1 and 4 papers
each (see Table 1).
Stage of the review process
In almost half of the papers (47.8%), the stage of the re-
view process at which stakeholders were involved was
unclear. In just over one quarter (27.5%), stakeholders
were involved in interpreting the results after the
Fig. 1 PRISMA flowchart
Table 1 Country in which stakeholder involvement took place/country of lead author
Total Patients/carers included No patients/carers included Unclear
USA 92 31.6% 18 19.6% 42 45.7% 32 34.8%
UK 76 26.1% 42 55.3% 16 21.1% 18 23.7%
Canada 29 10.0% 3 10.3% 17 58.6% 9 31.0%
Australia 22 7.6% 5 22.7% 7 31.8% 10 45.5%
Netherlands 14 4.8% 8 57.1% 4 28.6% 2 14.3%
Germany 12 4.1% 2 16.7% 8 66.7% 2 16.7%
Italy 7 2.4% 1 14.3% 4 57.1% 2 28.6%
France 6 2.1% 1 16.7% 3 50.0% 2 33.3%
Spain 5 1.7% 3 60.0% 1 20.0% 1 20.0%
Other (countries with < 5 papers*) 28 9.6% 5 17.9% 17 60.7% 6 21.4%
*Austria, China, Japan, Saudi Arabia, Switzerland, Belgium, Denmark, Norway, Brazil, Chile, Columbia, Iran, Korea, New Zealand, Taiwan
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evidence had been synthesised. In around one fifth
(22.3%), stakeholders were involved either throughout
the whole review process or during one or more stages
of review completion (see Table 2).
Focus of the review
Seventy-one percent of the included systematic reviews
were judged to be focussed on one of the International
Statistical Classification of Diseases and Related Health
Problems 10th Revision (ICD-10) categories (Table 3
and table of included studies (Additional file 7)). Most
frequently (10%), this was ‘factors influencing health sta-
tus and contact with health services’, where reviews cov-
ered topics such as the effectiveness or implementation
of care pathways for specific population (e.g. paediatrics,
geriatrics, emergency care). The specific diseases or
health areas covered by the greatest numbers of reviews
were mental and behavioural disorders (8.6%), neo-
plasms (6.9%), diseases of the musculoskeletal system
and connective tissue (6.2%) and certain infectious and
parasitic diseases (5.5%). Thirteen percent of the reviews
which did not fit one of the ICD-10 categories were fo-
cussed on a specific intervention, most commonly med-
ical or surgical interventions (8.6%) and public health
interventions (5.2%). Ten percent of reviews were fo-
cussed on an area of research, rather than a specific
health or disease area or intervention; more than half of
these (55%, n = 29) were focussed on methods of stake-
holder involvement or engagement, while the remainder
focussed on other areas of research methods, such as
methods of statistical tests within primary research. The
remaining 7% were unable to be categorised within any
of these groups and focussed on, for example, areas such
as teaching, data protection and criminal justice.
Comprehensiveness of description of method or
approach to involvement
Table 4 shows the assigned judgements of the compre-
hensiveness of the description of the method or ap-
proach to involvement. Figure 2 illustrates the
proportion of different types of paper which were judged
to be ‘green’, ‘amber’ or ‘red’, when patients/carers were
involved and at different stages in the review process.
In total, 59% of the included papers were judged to
provide few or inadequate details (‘red’), with only 10%
judged to provide a comprehensive description of one,
or more, method or approach to involvement (‘green’).
Detailed description of methods or approaches to
involvement
The 30 papers which were judged as providing a com-
prehensive (‘green’) description of their methods or ap-
proaches to involvement included 14 ‘methods’ papers
describing an experience of stakeholder involvement in
one (or more) systematic review [25, 29–41]; 11 system-
atic reviews in which the stakeholder involvement was
concurrently described [42–52]; 2 guidelines or clinical
recommendations, in which the involvement in the sys-
tematic review component was described [53, 54]; and 1
paper which described the development of a tool to re-
port stakeholder involvement [55]. Two of the papers
each described two different systematic reviews [37, 55],
meaning that there are a total of 32 systematic review
described. Table 5 summarises the key characteristics of
these 32 systematic reviews, and Table 6 summarises the
data relating to stakeholder involvement and a brief nar-
rative summary of key features is provided below.
Review aim/focus
Table 5 states the aim and focus of the 32 systematic
review. Sixty-eight percent were focussed on one of
the ICD-10 categories; with mental and behavioural
disorders being the most common health topic
(22%). Sixteen percent were focussed on a specific
intervention rather than a disease area, most com-
monly on a public health intervention (12%). The
remaining 16% were focussed on either research or
another topic.
A majority of the reviews (56%) synthesised both
qualitative and quantitative evidence, while 19% only in-
cluded quantitative studies and 12.5% only included
qualitative studies. The type of evidence included was
unclear for 12.5%. Two of the reviews described using a
‘realist’ review methodology, and 2 were Cochrane re-
views of randomised controlled trials.
Table 2 Stage of the review process in which stakeholders were involved
Total* Patients/carers involved No patients/carers involved Unclear
Setting scope/review questions 25 8.59% 8 32.00% 15 60.00% 2 8.00%
Interpreting results after review completion 80 27.49% 27 33.75% 39 48.75% 14 17.50%
Throughout/within the review process 65 22.34% 36 55.40% 24 36.90% 5 7.70%
unclear 139 47.77% 22 15.80% 52 37.40% 65 46.80%
*Percentages are calculated as percentage of the 291 papers with involvement at that stage. Total adds up to > 100%, as 18 papers involved stakeholders at both
setting scope/review questions and interpreting results after review completion and have therefore been counted within both of these categories
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Table 3 Focus of review
Total Patients/carers included No patients/carers included Unclear
Research 29 10.0% 16 55.2% 7 24.1% 6 20.7%
XXI Factors influencing health status and contact with health services 28 9.6% 9 32.1% 15 53.6% 4 14.3%
V Mental and behavioural disorders 25 8.6% 12 48.0% 4 16.0% 9 36.0%
II Neoplasms 20 6.9% 7 35.0% 7 35.0% 6 30.0%
ICHI Medical and surgical intervention 20 6.9% 1 5.0% 12 60.0% 7 35.0%
XIII Diseases of the musculoskeletal system and connective tissue 18 6.2% 6 33.3% 10 55.6% 2 11.1%
I Certain infectious and parasitic diseases 16 5.5% 4 25.0% 10 62.5% 2 12.5%
ICHI Public health intervention 15 5.2% 3 20.0% 8 53.3% 4 26.7%
XI Diseases of the digestive system 14 4.8% 0 0.0% 6 42.9% 8 57.1%
X Diseases of the respiratory system 13 4.5% 2 15.4% 8 61.5% 3 23.1%
IV Endocrine, nutritional and metabolic diseases 12 4.1% 1 8.3% 6 50.0% 5 41.7%
IX Diseases of the circulatory system 12 4.1% 2 16.7% 4 33.3% 6 50.0%
XII Diseases of the skin and subcutaneous tissue 8 2.7% 3 37.5% 4 50.0% 1 12.5%
XIV Diseases of the genitourinary system 8 2.7% 3 37.5% 3 37.5% 2 25.0%
XV Pregnancy, childbirth and the puerperium 8 2.7% 4 50.0% 2 25.0% 2 25.0%
XIX Injury, poisoning and certain other consequences of external causes 7 2.4% 0 0.0% 3 42.9% 4 57.1%
VI Diseases of the nervous system 5 1.7% 2 40.0% 2 40.0% 1 20.0%
Categories with < 5 papers* 14 4.8% 7 50.0% 1 7.1% 6 42.9%
Other (unable to categorise) 19 6.5% 6 31.6% 7 36.8% 6 31.6%
Note: no papers were categorised as XVI Certain conditions originating in the perinatal period; XVIII Symptoms, signs and abnormal clinical and laboratory
findings, not elsewhere classified
*III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism; VII Diseases of the eye and adnexa; VIII Diseases of
the ear and mastoid process; XVII Congenital malformations, deformations and chromosomal abnormalities; XX External causes of morbidity and mortality; ICHI
Functioning intervention
Table 4 Comprehensiveness of description of method or approach to involvement
Comprehensiveness ‘Green’ ‘Amber’ ‘Red’
Comprehensive description of one (or
more) specific method or approach to
the involvement in systematic reviews.
Description sufficient to enable
replication of methods
A brief or partial description of one (or
more) specific method or approach to
the involvement in systematic reviews.
Description sufficient to enable partial
replication of methods
Few details provided and/or inadequate
description of the method or approach
of involvement. Description insufficient
to enable any replication of methods
Total 30 88 173
Were patients/consumers involved?
Yes 24 37 27
No 5 38 76
Unclear 1 13 70
Stage at which there was involvement*
Setting scope/
review questions
7 11 7
Interpreting
results after
review
completion
10 41 29
Throughout/
within the
review process
15 29 21
Unclear 1 18 120
*18 papers involved stakeholders at both setting scope/review questions and interpreting results after review completion; 3 were judged as ‘green’, 11 as ‘amber’
and 4 as ‘red’
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People involved
Seventy-eight percent of the systematic reviews involved
patients, carers or family members, while in one (3%),
the people involved were peer support workers. In 19%
of systematic reviews, the only people involved were
professionals or academic experts, although one of these
[56] aimed to recruit patient representatives, but failed
to do so. Where there were face-to-face meetings, the
number of stakeholders involved ranged from 2 to 27;
where there were one-off events, often advertised as
open to the general public, the numbers of stakeholders
involved ranged from 15 to 81; where involvement did
not require a face-to-face meeting, for example using an
electronic Delphi or survey, the numbers invited ranged
from 29 to 340 (see Table 6).
Geographical location (from which stakeholders were
recruited)
The majority of the involvement occurred in the UK,
with two thirds (66%) of papers describing UK-based
activities. Of the remaining 34%, 2 recruited people
from across Europe, 3 were carried out in Canada, 3
in the Netherlands and 1 in Australia, USA and
Spain.
How people were recruited
For 69% (22/32) of the systematic reviews, people were
personally invited to be involved. This involved personal
invitations to known people (in 12/22; [29, 31, 39, 41–
44, 48, 54, 55, 57]); personal invitations to an existing
group or groups (in 6/22; [34, 35, 37, 46, 58]); or purpos-
ive sampling, using similar methods as sampling for
qualitative research (in 4/22; [32, 38, 40, 56]). For a fur-
ther 7/32 of the systematic review, involvement oppor-
tunities were advertised to the general population, often
snowballing information out via target groups and orga-
nisations, and anyone who volunteered could get in-
volved [25, 36, 47, 49, 50, 52, 53]. A combination of
different recruitment strategies was used for 1 systematic
review [33], and the method of recruitment was unclear
for 3 systematic reviews [30, 45, 51].
Fig. 2 Bubble plot illustrating proportion of papers in which patients/carers were included, the stage of the review process at which people were
involved and the comprehensiveness of the description of the method of involvement
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Table 5 Key characteristics of ‘green’ systematic reviews
Review Geographical
location
Type of paper Review aim/focus Focus of review* Type of
evidence
synthesised**
Bayliss et al.
[29]
Europe (UK,
Sweden,
Estonia,
Romania)
Description of methods of
involvement (describes results of
questionnaire-based evaluation of the
involvement)
Qualitative meta-synthesis; perceptions
of predictive testing for those at risk of
developing a chronic inflammatory
disease
XIII Diseases of the
musculoskeletal
system and
connective tissue
Qualitative
Boelens et al.
[30]
Europe Description of methods of
involvement (describes the consensus
process to develop statements and
recommendations to include in a
patient summary)
Patient summary of consensus for colon
and rectal cancer care
II Neoplasms Unclear
Bond et al.
[53]
Australia Report of a guideline/
recommendation
Guidelines; assisting Australians with
mental health problems and financial
difficulties.
V Mental and
behavioural
disorders
Mixed
Braye and
Preston-Shoot
[31]
UK Description of methods of
involvement (researcher’s experiences
of involving stakeholders)
Systematic review; learning, teaching
and assessment of law in social work
education
Other Mixed
Bunn et al.
[32]
UK Description of methods of
involvement (method to contextualise
findings of a review)
Systematic review of qualitative studies;
patient and carer experiences of
diagnosis and treatment of dementia
V Mental and
behavioural
disorders
Qualitative
Concannon et
al. [42]
USA Systematic review Systematic review; methods of
stakeholder engagement in comparative
effectiveness research and patient-
centred outcomes research
Research Mixed
Coon et al.
[63]
UK Description of methods of
involvement (describe and discuss
methods of involvement in 4 reviews)
Four systematic reviews;
nonpharmacological interventions for
ADHD used in school settings
V Mental and
behavioural
disorders
Mixed
Edwards et al.
[43]
UK Systematic review Identification, assessment and
management of risk in young people
with complex mental health needs
entering, using and exiting inpatient
child and adolescent mental health
services in the UK
V Mental and
behavioural
disorders
Mixed
Harris et al.
[25]
UK Description of methods of
involvement (describe and discuss
methods of involvement in a realist
review)
Realist review; community-based peer
support
ICHI Functioning
intervention
Mixed
Hayden et al.
[44]
Canada Systematic review Rapid knowledge synthesis;
Collaborative Emergency Centres (CECs)
XXI Factors
influencing health
status and contact
with health
services
Unclear
Higginson et
al. [45]
UK Systematic review Systematic review; design and conduct
of research on end of life care (EoLC)
XXI Factors
influencing health
status and contact
with health
services
Mixed
Hyde et al.
[34]
UK Description of methods of
involvement
Systematic review and narrative
synthesis; factors affecting shared
decision-making around prescribing an-
algesia for musculoskeletal pain in pri-
mary care consultations
XIII Diseases of the
musculoskeletal
system and
connective tissue
Mixed
Jamal et al.
[35]
UK Description of methods of
involvement
Systematic review; effects of schools and
school environment interventions on
children and young people’s health
XXI Factors
influencing health
status and contact
with health
services
Mixed
Liabo [46] UK Description of methods of
involvement
Systematic review; effectiveness of
interventions that aim to support looked
after children in school
XXI Factors
influencing health
status and contact
with health
Mixed
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Table 5 Key characteristics of ‘green’ systematic reviews (Continued)
Review Geographical
location
Type of paper Review aim/focus Focus of review* Type of
evidence
synthesised**
services
Liu et al. [47] UK Systematic review Mixed-methods systematic review; to
identify, appraise and interpret research
on the approaches employed to
maximise the cross-cultural appropriate-
ness and effectiveness of health promo-
tion interventions for smoking cessation,
increasing physical activity and improv-
ing healthy eating for African-, Chinese-
and South Asian-origin populations
ICHI Public health
intervention
Mixed
Martin et al.
[36]
UK Description of methods of
involvement
Systematic review; attitudes and
preferences toward population
screening for dementia
V Mental and
behavioural
disorders
Mixed
McConachie
et al. [48]
UK Systematic review Systematic review; measurement
properties of tools used to measure
progress and outcomes in children with
autistic spectrum disorder (ASD) up to
the age of 6 years
V Mental and
behavioural
disorders
Quantitative
McCusker et
al. [49]
Canada Systematic review Systematic review; collaborative mental
health care for depression
V Mental and
behavioural
disorders
Mixed
McGinn et al.
[56]
Canada Systematic review Systematic review; users’ perspectives of
the factors influencing electronic health
record (EHR) implementation
XXI Factors
influencing health
status and contact
with health
services
Quantitative
Morgan et al.
[58]
UK Systematic review Systematic review (quantitative and
qualitative evidence); incentive
mechanisms of action for smoking
cessation in pregnancy and
breastfeeding
XV Pregnancy,
childbirth and the
puerperium
Mixed
Oliver et al.
[37]
(‘correlational’
review)
UK Description of methods of
involvement
Systematic review of observational
studies (a ‘correlational’ review); to
explore the quantitative relationship
between childhood obesity and
educational attainment
ICHI Public health
intervention
Quantitative
Oliver et al.
[37] (‘views’
review)
UK Description of methods of
involvement
Systematic review of interview-based
and questionnaire-based research
(‘views review’); children’s perspectives
of body size
ICHI Public health
intervention
Qualitative
Oosterkamp
et al. [54]
Netherlands Report of a guideline/
recommendation
Systematic review; strategies to prevent
WSL (white spot lesions) during
orthodontic treatment with fixed
appliances
XI Diseases of the
digestive system
Quantitative
Pearson et al.
[50]
UK Systematic review (description of
involvement in supplementary file)
Realist review; conditions and actions
which lead to the successful
implementation of health promotion
programmes in schools
ICHI Public health
intervention
Mixed
Pollock et al.
[38]
UK Description of methods of
involvement
Cochrane review; physical rehabilitation
approaches for the recovery of function
and mobility in people with stroke
IX Diseases of the
circulatory system
Quantitative
Rees et al. [51] UK Systematic review Systematic review; barriers to, or
facilitators of, HIV-related sexual health
for men who have sex with men (MSM)
and MSM’s perceptions and experiences
of sexual health in the light of HIV
I Certain infectious
and parasitic
diseases
Mixed
Saan et al.
[55] (review 1)
Netherlands Other (development of reporting tool) Qualitative evidence synthesis; needs of
victims of crime with regard to helpful
and unhelpful reactions of their social
Other Qualitative
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Format of involvement
The format of involvement comprised direct,
face-to-face interaction in 81% and an electronic Del-
phi method or survey in 19% of the systematic re-
views. The face-to-face interaction was either in the
format of a meeting (53%; [29, 31, 32, 34, 35, 38, 40–
44, 46, 50, 52, 55, 58]), a larger workshop or public
event (19%; [25, 36, 37, 47, 49]) or a combination of
both of these (9%; [33, 45, 48]). In each of the 6/32
systematic reviews which used an electronic Delphi
method, there was a specific and focussed aim of
stakeholder involvement; in 4/32 [30, 53, 54, 56], this
was broadly related to reaching consensus on factors,
recommendations or statements arising from the re-
sults of the systematic review, and in 2/32 [39, 55],
this was to reach consensus on the topic or focus of
the systematic review.
Amount of involvement
Where there was direct face-to-face interaction, there
could be between 1 and 20 meetings or events. The
majority (83%) of the 24 reviews providing this infor-
mation held 4 or less meetings (median 2 meetings),
while one held 5 meetings plus 3 public workshops
[45]. Three held multiple meetings (12, 15 and 20
respectively by [25, 46, 58]); in each of these three
examples, the approach is described as ‘participatory’.
Where reported, the length of face-to-face meetings
varied from 1 h to ½ day. Generally, the Delphi
approach involved three rounds of an electronic
survey, although in one example after two rounds of
Delphi voting there was a direct face-to-face consen-
sus meeting [54].
Ethical approval
Details of ethical approval were reported for 31% of
systematic reviews; for details, see Table 6. One paper
reported that ethical approval was sought but not re-
quired [44]. No details relating to ethical approval
were provided by the remaining 66% of papers.
Financial compensation
Expenses (such as travel, accommodation and care
costs for family members) were reported to be paid
to people involved in 25% of systematic reviews; in
two, this was expenses only, while in six money or a
voucher was provided in addition to expenses (see
Table 6). No details relating to financial compensation
are reported in the remaining 75% of systematic
reviews.
Tools or method of reporting involvement
Thirty-four percent of the included papers had a clear
method of reporting involvement. Four used some sort
of tool, framework or checklist: Concannon et al. [42]
developed and used a 7-item question for reporting
stakeholder involvement in research, Liabo [46] used a
framework for considering impact of involvement,
Martin et al. [36] reported an evaluation based on
reporting standards within Guidance for Reporting
Table 5 Key characteristics of ‘green’ systematic reviews (Continued)
Review Geographical
location
Type of paper Review aim/focus Focus of review* Type of
evidence
synthesised**
network including volunteer services
Saan et al.
[55] (review 2)
Netherlands Other (development of reporting tool) Systematic review; concepts,
determinants and outcome measures
used to evaluate self-management
support
Other Unclear
Serrano-
Anguilar et al.
[39]
Spain Description of methods of
involvement
Systematic review; effectiveness and
safety of treatment alternatives for
patients with degenerative ataxias (DA)
VI Diseases of the
nervous system
Unclear
Smith et al.
[52]
UK Systematic review ‘Multi-methods review’; service user
involvement in nursing, midwifery and
health visiting research
Research Mixed
Stewart and
Oliver [40]
UK Description of methods of
involvement
Systematic review of reviews;
communication with parents about
newborn bloodspot screening
XV Pregnancy,
childbirth and the
puerperium
Mixed
Vale et al. [41] UK Description of methods of
involvement
Cochrane review; chemoradiotherapy for
cervical cancer
II Neoplasms Quantitative
Note that within this table there are 32 reviews described, as 2 of the 30 included papers describe 2 reviews, and data has been extracted separately for these at
this stage (Oliver et al. [37] ‘correlational’ review and ‘views’ review; Saan et al. [55] review 1 and review 2)
*Focus of review categorised as either: Health/disease of focus according to ICD-10 categories; OR, if review was not focused on a specific health topic/disease,
then review was categorised as either: Medical or surgical intervention, Public health intervention, Functioning intervention, Research, or Other
**Type of evidence synthesised categorised as qualitative, quantitative, mixed (i.e. both qualitative and quantitative) or unclear
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
Bayliss et al.
[29]
‘Patient research
partners’ contributed
via teleconference
calls, written (email)
and one face-to-face
meeting.
Teleconferences:
during completion of
searches and paper
selection, to input
into search
By email: 3 volunteers
helped with coding
framework to
coproduce themes
with researchers
Meeting: invited to
attend a 90-min face-
to-face focus session
at an annual meeting
Women with
rheumatoid arthritis
(n = 8); all with
understanding of the
research process
‘Patient research
partners’—teleconferences,
emails and invitation to
one 90-min meeting
– No information
provided
No information
provided
Boelens et al.
[30]
Experts participated
in three web-based
online voting rounds,
discussion and lec-
tures at a conference.
Patients and patient
representatives were
involved in the
Delphi and had a role
in developing a
patient summary and
future testing and
implementation of
this patient version.
Drafts of the patient
summary were
circulated by email,
and comments
invited.
‘Experts’
(professionals).
People who were
colon or rectal cancer
survivors and
representatives of this
group.
Delphi approach (online, 3
rounds)
‘In the Delphi online voting
process, 32 delegates were
able to vote. Patient
representatives had one
vote. It is not known how
many patients attended
the meeting.’
Delphi
approach
No information
provided
No information
provided
Bond et al.
[53]
Statements arising
from a systematic
review were used to
form a questionnaire
that was
administered to the
expert panels via
SurveyMonkey. The
panel members were
asked to rate each of
the statements, using
a 5-point scale, ac-
cording to whether
or not they thought
the statement should
be included in the
guidelines.
Five expert panels:
financial counsellors,
financial institution
staff, mental health
professionals, mental
health consumer
advocates and carer
advocates. All
panellists had to be
18 years or older,
living in Australia, and
have either
professional or
personal experience
with mental health
problems and
financial difficulties.
Delphi approach (online, 3
rounds)
(340 participants invited;
214 completed round 1,
170 completed round 2,
162 completed round 3)
Delphi
approach
Ethical approval
granted.
No information
provided
Braye and
Preston-Shoot
[31]
The first meeting
aimed to seek views
on the content and
process of the study,
finalising the research
questions and
concluding the
protocol, and to
Service users and
carers (n = 15),
professionals (n = 16)
Two face-to-face meetings.
Information was sent out
prior to meetings,
introductory presentation.
– No information
provided
In addition to
researcher time to
undertake these
negotiations,
money was also
set aside to meet
the costs of travel
and special
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
explore and consider
participants
perspectives around
the topic. The second
meeting aimed to
present and consider
emerging findings
and agree
recommendations for
the final report, and
to consider the
broader implications.
transport,
accommodation
and fees related
to attendance........
. It was self-
evident here that
individuals, or
their organisa-
tions, should be
paid for their
time, immediately
in cash when
required.
Bunn et al.
[32]
Focus groups and
interviews with key
stakeholders.
Involvement occurred
after completion of
the systematic review,
in order to confirm
the key themes from
the review.
27 participants (three
people with
dementia, 12 carers,
six dementia service
providers and five
older people without
dementia).
Purposive sampling
approach to
recruitment.
Four focus groups and
three interviews
Focus groups,
interviews
Ethical approval
was obtained
from NRES
Committee East
of England. REC
reference 10/
H0302/19.
Participants were
given a £10
voucher in
appreciation of
their time, and
their travel
expenses were
reimbursed.
Concannon et
al. [42]
Two meetings at
different stages in the
review process.
Meeting 1 aimed at
confirming the
research questions
and study design.
Meeting 2 to review
preliminary results.
Group members also
participated by email
and phone,
commenting on
tables, figures and
manuscript drafts,
and were asked to
assist in
dissemination.
In addition, 3 people
(2 patients)
contributed to review
the planning stages.
Consumers,
professionals,
researchers (n = 7)
Two face-to-face meetings.
Email and phone
communication
throughout the review.
– No information
provided
No information
provided
Coon et al.
[63]
An Expert Advisory
group—involved
throughout the
project, including
commenting on the
protocol, editing draft
chapters and
responding to ad hoc
questions.
In addition, a series of
four events were
held: Event 1 aimed
Expert advisory
group—academics,
charity
representatives,
professionals.
Four events: Event 1
(n = 15), parents,
carers, professionals,
researchers. Event 2
(n = 20), professionals.
Event 3 (n = 25),
parents and young
Expert advisory group.
Four events.
– No information
provided
No information
provided
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
to share information
and explore
experiences. Events 2
and 3 aimed to
explore interim
findings of the
review. Event 4
disseminated
findings.
people. Event 4 (n =
60), parents,
professionals, policy
makers.
Edwards et al.
[43]
Individual
interviews—aimed at
identifying topics for
review to focus on.
Meeting—descriptive
maps from initial
scoping review/
mapping exercise
were presented.
Informed by the
principles of nominal
group technique,
participants
generated
independent lists of
important topics,
which were collated
and displayed.
Individual participants
then ranked, in
writing, their personal
priorities from the list.
Individual interviews
(n = 6), with young
people (patients) or
their carers.
Face-to-face
meeting—health
professionals, young
people, charity
representative (n = 7),
plus research team (n
= 7)
Two methods:
1) Individual interviews
2) Face-to-face meeting
Consensus
decision-
making tech-
niques: nom-
inal group
technique
No information
provided
No information
provided
Harris et al.
[25]
Five ‘cross-
organisation’ events
and seven ‘within-
organisation’ events.
Also email discussions
and opportunistic
contact with
researchers.
Recruitment to the
advisory network
took place
throughout the
review, and different
individuals had
different levels of
involvement, and at
different stages. Some
members contributed
on multiple occasions
and others only on a
single occasion.
‘Advisory
network’—salaried
workers, health
trainers, volunteer
health champions
and programme
coordinators with
expertise in using
peer support, and
people who had
originally received
support before going
on to become a peer
support worker.
Total of 12 meetings
(approximately 240 face-to-
face contacts with around
120 participants)
Format—various, including
use of notes, flip charts,
audio recording, post-it
notes
Participatory
approaches
No information
provided
No information
provided
Hayden et al.
[44]
Workshop 1 = The
goals of the
stakeholder workshop
were to discuss
methods for evidence
synthesis in general;
Selected local
stakeholders (n = 19)
(professionals; no
consumers involved)
Group meetings (2) (half
day). Voting for
prioritisation.
Format—activities and
small group discussions to
engage attendees, to
– No information
provided
No information
provided
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
to discuss the
objectives and
approach of our
specific project; to
refine definitions and
priorities within the
project; and to
discuss key findings,
key messages, and
dissemination plans.
Workshop 2 = Key
messages and the
data tables were
discussed at a second
stakeholder
workshop.
encourage discussion, and
to reach consensus.
Higginson et
al. [45]
‘Transparent expert
consultations (TEC)’
involving consensus
methods of nominal
group and online
voting, and
stakeholder
workshops.
Panel of experts in
trials, quantitative,
qualitative and mixed-
method research,
within and outside
palliative care, pa-
tients/consumers, ser-
vice providers,
clinicians, commis-
sioners, national pol-
icy makers and
voluntary sector
representatives
Transparent Expert
Consultation (5 meetings).
3 workshops—2 with
patients/consumers, 1 with
clinicians/policy makers
Transparent
Expert
Consultation
(incorporates
NGT)
Ethics
The research
ethics committee
of the University
of Manchester
(reference
number 10328)
approved the TEC
component of
MORECare. All
TEC participants
gave written
consent.
No information
provided
Hyde et al.
[34]
Three meetings at
different stages in the
review process.
Meeting 1 took place
during the protocol
design stage and
aimed at refining the
scope of the review.
Meeting 2 took place
at the review
preliminary findings
stage, aimed at
interpreting the
results and planning
the dissemination.
Meeting 3 took place
at the writing up
stage, aimed at
agreeing final results
and planning how to
share results.
Patients (n = 5),
members of an
established patient
research user group
(patients with
musculoskeletal
conditions)
Each face-to-face meeting
was 3 h.
Format of meetings were a
mixture of presentations
with discussion, and using
‘small group techniques’
– No information
provided
No information
provided
Jamal et al.
[35]
Meeting 1—aimed at
informing developed
of review questions.
Discussion around
key terms and
perspectives of
potential
interventions.
Researchers used data
from meeting to
generate topics.
Meeting 2—aimed at
prioritising topics.
Young people (n = 13
for meeting 1, and n
= 13 for meeting 2),
from an existing
young people’s public
involvement in
research group (the
existing group had 25
members, who were
recruited via
advertisements. The
group met monthly).
Face-to-face meetings
Meetings were 1 h.
Meetings involved short
presentations and group
discussion.
Meetings were
‘supplemented with an
online discussion forum’.
Meeting 1 and online
discussion forum
generated list of health
topics. Meeting 2 agreed a
final list and voted
Consensus
decision-
making tech-
niques: vot-
ing/ranking
No information
provided
Members were not
rewarded directly
from researchers.
However, they
received £15
vouchers for their
monthly
participation (not
specific to this
research project),
had food and
transport provided
and were eligible
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
Discussion around list
of topics generated
from meeting 1,
followed by voting
for topics considered
most important for
systematic review.
Five priority
systematic reviews
were then carried out
by the researchers.
individually to prioritise. for an annual
residential
teambuilding
activity.
Liabo [46] A participatory
approach was used
to involve a group of
young people in all
stages of a review.
Young people (total
of 20 people across
all meetings; 5 people
only came to 1
meeting, others to
multiple meetings; 2
came to all meetings).
Target group was
young people (up to
age of 25) with
experience of being
in care.
20 review meetings ‘Participatory
methods’
The study was
granted ethical
approval by the
Institute of
Education ethics
committee
(application
number FCH 62)
in November
2007.
This study adapted
the payment
regulations
operated by PAS,
which was a fixed
amount per hour,
specified for
meetings, training
(half of meetings)
and presentations
(higher than
meetings).
Liu et al. [47] User engagement
was undertaken
throughout our
project through the
inclusion of lay
members on our
Independent Project
Steering Committee;
in addition, we held
two user conferences,
one to launch the
study and one to
share and discuss our
preliminary findings.
A total of 81
delegates attended
the first conference,
and 71 the second
conference, from a
wide variety of
stakeholder
organisations.
Independent Project
Steering Committee
Two meetings:
1. To obtain feedback on
the research proposal and
methods
2. To present and discuss
preliminary findings
– Ethical
arrangements
outlined in
protocol, but
unclear if formal
ethical approval
applied for or
granted
No information
provided
Martin et al.
[36]
A PPI (patient and
public involvement)
event was organised
to facilitate members
of the public in the
East of England to
talk about their views
on population
screening for
dementia. The aim
was to contextualise
the findings of a
systematic review for
a British audience.
Purposive approach
(50 invited, 36
attended)
Meeting (1 all day public
event). Held during the
final stages of the
systematic review
‘Quasi-focus
group format’
No information
provided
In recognition of
participants’ time
and to mitigate
the risk of
participant
dropout, a fixed
monetary
honorarium of £80
was offered and
reminder calls
were made in
advance of the
event. Costs for
supportive care
were provided to
partners if they
attended without
their care
recipients, and
travel costs
McConachie
et al. [48]
A ‘multifaceted
approach to
consultation’,
including (1)
consultation with
young people with
People with ASD—12
young people and 8
adults responded.
Health
professionals—838
survey respondents
Methods included
meetings, survey and
emails.
Q-sort for
rating
agreement
with
outcomes
No information
provided
Young people:
‘Each respondent
was given a
shopping voucher
in
acknowledgement
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
ASD, in groups and
by email; (2) survey of
health professionals;
(3) consultation with
parents—3 meetings
throughout review
process; (4) multiple
stakeholder
discussion day about
the preliminary
conclusions of the
review.
Parents—7
participated in one or
more meetings
Multiple stakeholder
day—16 people
of their
contribution’.
Parents: ‘Parents
were given a
financial
acknowledgement
in addition to
travel expenses, to
recognise their
time and expertise
at each
attendance’.
McCusker et
al. [49]
A literature review on
collaborative mental
health care for
depression was
completed and used
to guide discussion at
an interactive
workshop. The
workshop was held
as part of pre-
conference activities
at the June 2011 Can-
adian Conference on
Collaborative Mental
Health Care in Halifax,
Nova Scotia.
We invited a
spectrum of
stakeholders to
participate, aiming to
have roughly equal
representation of 4
groups: primary care
providers, mental
health providers,
decision makers and
consumers.
Workshop (n = 40; 9
members of planning
committee and 31 invited
stakeholders)
Survey, to rate agreement
with themes arising from
workshop (n = 21/42, 50%
response rate)
Thematic
analysis of
workshop
discussion
The protocol was
approved by the
St Mary’s Hospital
Research Ethics
Committee.
Participants
provided oral but
not written
consent to
participate.
Permission was
requested at the
workshop for the
proceedings to
be audio-
recorded and
photographed,
and for the partic-
ipants’ names and
affiliations to be
listed in the final
report. As one
person did not
agree to audio re-
cordings, no re-
cordings were
made.
No information
provided
McGinn et al.
[56]
A Delphi study
among Canadian
representatives of
actual or potential
EHR users to confirm
the findings of the
systematic review and
to prioritise the key
barriers and
facilitating factors for
EHR implementation
in Canada.
106 participants: 14
physicians, 30
healthcare
professionals, 33
managers, 29 health
information
professionals (0
patient
representatives due to
low recruitment).
Delphi—3 rounds: 83
participants completed
round 1, 69 round 2 and
63 round 3.
Delphi
approach
Ethics approval
for the study
protocol was
received from the
Research Ethics
Board of the
Centre Hospitalier
Universitaire de
Québec
(approved
January 23, 2009;
ethics number 5-
08-12-06).
No information
provided
Morgan et al.
[58]
As part of a
partnership approach
for a wider project
relating to incentive
mechanisms for
smoking cessation in
pregnancy and
breastfeeding, 2
mother-and-baby
groups were recruited
and were co-
applicants on the
Members of 2 existing
groups (groups of
around 12 people).
Groups were mother
and baby/toddler
groups.
15 meetings (during
project, not just systematic
review component).
Members contributed to
interpretation of systematic
review findings by
providing feedback on a
number of vignettes of
studies included in the
evidence synthesis.
‘Participatory’ Although the
service user
collaborators
were
independent or
local government
representatives,
rather than NHS
groups, we
considered it
preferable to gain
ethics committee
No information
provided
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
wider project. approval before
active
engagement,
particularly
because the
groups had not
been involved in
research before.
Oliver et al.
[37]
(‘correlational’
review)
A one-off workshop/
meeting with mem-
bers of an existing
group. The workshop
was scripted. Ground
rules were
established.
Literature had been
screened but not
synthesised:
involvement explored
variables and
pathways that had
been examined in the
literature, aiming to
contribute to a
theoretical framework
to help synthesise
study findings.
Young people, aged
12–17 years
(approximately 12)
One meeting (2.5 h).
Format: discussion, ranking
of themes
Used methods
for ranking of
importance
(stickers and
ranking cards),
but these did
not directly
inform
decision-
making
No information
provided
No information
provided
Oliver et al.
[37] (‘views’
review)
A one-off workshop/
meeting with mem-
bers of an existing
group. The workshop
was scripted. Ground
rules were
established.
The synthesis of
literature was almost
complete; the aim of
involvement was to
provide a check on
the credibility of the
synthesis and
develop review
implications.
Young people, aged
12–17 years
(approximately 12)
One meeting (2.5 h).
Format: discussion, ranking
of themes
As above No information
provided
No information
provided
Oosterkamp
et al. [54]
RAND-e modified
Delphi (2 rounds)
Group (consensus)
meeting
The purpose of the
involvement was to
develop consensus
on statements on the
prevention of WSL
during orthodontic
treatment with fixed
appliances.
The expert panel
comprised 11
representatives, all
graduated dentists,
from research,
education,
orthodontics,
cariology, general
dentistry and advisory
general dental
practitioners from
health insurance
companies.
RAND-e modified Delphi
procedure (involves
considering patient
vignettes).
Consensus meeting
Delphi
approach
No information
provided
No information
provided
Pearson et al.
[50]
Two meetings at
different stages in the
review process.
Meeting 1 took place
at the start of the
review and aimed to
‘sharpen the focus of
Professionals (n =
10)—primary and
secondary school-
level educational pro-
fessionals and senior
academics linked to
the review
Two face-to-face meetings
(length unclear)
– No information
provided
No information
provided
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
the review so that it
would be relevant to
those directly
involved in the
implementation’.
Meeting 2 took place
when a draft of the
review was complete,
aimed at getting
feedback on this
draft.
Pollock et al.
[38]
Three meetings at
different stages in the
review process.
Meeting 1 aimed to
explore how the
intervention could be
categorised within
the review. Meeting 2
aimed to explore and
agree on specific
strategies to update
and amend the
current Cochrane
systematic review,
based on the
decisions made
during meeting 1.
Meeting 3 aimed to
explore the perceived
clinical implications of
the findings.
Patients, carers,
professionals (n = 13)
Three face-to-face meet-
ings (half day meetings)
Additional contact by email
throughout review.
Nominal
group
technique
The project was
approved by the
Glasgow
Caledonian
University School
of Health and Life
Sciences ethics
committee
(Reference:
HLS12/40).
We costed for the
direct expenses
associated with
involvement (that
is, travel,
subsistence), but
not for any
funding to pay for
the time of group
members.
Rees et al. [51] An advisory group,
which met 3 times
during the project.
The specific tasks for
the group included:
• Advising on the
most appropriate
terminology relevant
to the subject area;
• Identifying the
literature, particularly
unpublished reports;
• Identifying and
prioritising a priori
outcomes for
analysis;
• Informing decisions
the review team
had to make at key
stages of the review;
• Helping to
disseminate the
work through
incorporating its
findings into
members’ respective
areas of work, and
publicising the
review to colleagues
and associates.
Researchers/
academics, policy
specialists, voluntary
sector workers, and a
practitioner,
representing a
number of
organisations (n = 7)
Three face-to-face meet-
ings, of around 2 h.
Format—meetings were
‘semi-informal’, involving
presentations, discussions
and explicit consensus
methods (voting)
Consensus
decision-
making tech-
niques: voting
No information
provided
No information
provided
Saan et al.
[55] (review 1)
‘A partnership
between the
Academic experts (n
= 2)
‘discussion’
Format unclear
– No information
provided
No information
provided
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Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
commissioner and
researchers’
Saan et al.
[55] (review 2)
Participants in an
anonymous online
Delphi process: ‘39
experts from the
Netherlands (34
researchers and five
policy advisors) were
invited by email. They
were contacted
through the contact
list of a recent expert
meeting on self-
management in the
Netherlands and
through the profes-
sional network of
members of the re-
search group.’
Academic experts (29
invited: 20 completed
first round of Delphi,
17 second round, 16
third round)
Anonymous online Delphi Consensus
decision-
making tech-
niques: Delphi
No information
provided
No information
provided
Serrano-
Anguilar et al.
[39]
Three rounds of
electronic Delphi.
Round 1—an open
questionnaire to
explore the
treatments used by
patients and
perceived health
problems associated
with their disease.
Round 2—aimed at
prioritising the health
problems identified in
the first round. Round
3—aimed at reaching
final consensus.
Patients with DA (n =
53)
Electronic Delphi (3
rounds)
Consensus
decision-
making tech-
niques: Delphi
method
This study was
approved by the
Ethics Committee
of the Canary
Islands since its
coordination was
carried out by the
Planning and
Evaluation Unit of
the Canary Islands
Health Service
No information
provided
Smith et al.
[52]
A ‘reference’ group
was set up for the
project. There were 3
face-to-face meetings
at different stages in
the review. Meeting 1
was aimed at sharing
ideas and agreeing
how the group would
work. Meeting 2 dis-
cussed the scope and
remit of the review.
Meeting 3 was aimed
at identifying key
messages from the
findings and planning
dissemination.
Additional
communication
between researchers
and the reference
group occurred by
telephone
conversations, email,
project website and
newsletters.
Service user and carer
advocacy group
members (n = 26)
Three face-to-face meet-
ings (length unclear)
– No information
provided
No information
provided
Steward and The wider project aim 22 parents, with Group meetings (3), over – No information Paid:
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Involvement of Patients and the Public (GRIPP) check-
list [59] and Saan et al. [55] developed and used a Tool
for Recording and Accounting for Stakeholder In-
volvement (TRASI). Seven specifically reported activ-
ities which groups of stakeholders were involved in
within a specific section of text, tables or supplemen-
tary files [30, 35, 37, 38, 47, 50]. Within the
remaining 66% of systematic reviews, information
about methods of involvement was not reported
within a particular section, table or file, but was dis-
tributed throughout the paper.
Evaluation of the methods of involvement
None of the 32 studies carried out any formal evaluation
of the impact of involving stakeholders; however, 28%
collected data relating to the views and experiences of
Table 6 Summary of data relating to stakeholder involvement in ‘green’ systematic reviews (Continued)
Review Description of
involvement
People involved Method of involvement Formal
research
methods
Ethical approval? Financial
compensation (or
alternative) for
people involved?
Oliver [40] was to ensure that
policies and resources
arising from the
systematic review
were relevant to
parents, taking into
account their
experiences and
views. Policy and
resources were
developed by 12
multi-disciplinary ex-
pert groups. Parents
were included in
these expert groups
to share experiences
and join discussions.
experiences of
newborn screening
an 18-month period. provided • Parents’ travel
expenses to and
from meetings
• For coffee at pre-
meetings
• Honoraria for
parents
equivalent to £17
per hour at each
meeting, given in
gift
vouchers: this
came to £75–£100
for each meeting
• A fee to
organisations that
assisted with
recruitment, in
recognition of
the support these
organisations
provided to
parents. The fee
was either £8 per
hour of meeting
attended by their
members, or
later, because this
became too
difficult to
administer, a
one-off £50 fee
per parent
recruited.
Vale et al. [41] Patient research
partners had an initial
face-to-face meeting,
then contributed to a
number of review ac-
tivities, including ‘pro-
viding feedback on
the detailed informa-
tion folders, helping
to trace contact de-
tails for trial investiga-
tors, learning about
data management
and analysis and con-
tributing to regular
project newsletter’
(1) Reference
group—professionals,
patient/charity
representatives,
patient (n = 7)
(2) Patient research
partners—women
who had received
treatment for cervical
cancer (n = 6)
‘Patient research
partners’—also
contributing to another
research project—around 6
meetings/year. Additional
communication via email
– No information
provided
No information
provided
Note that within this table there are 32 reviews described, as 2 of the 30 included papers describe 2 reviews, and data has been extracted separately for these at
this stage (Oliver et al. [37] ‘correlational’ review and ‘views’ review; Saan et al. [55] review 1 and review 2)
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people involved. Of these, four used a questionnaire to
elicit the views and experiences of stakeholders [29, 30,
36, 41]; three held a discussion with stakeholders in
which they were encouraged to share or reflect on their
experiences and perspectives [31, 33, 47]; and two had
both a questionnaire and a discussion [38, 44]. In
addition, Liabo [46] reported data arising from audio re-
cordings and minutes of all meetings, Hyde et al. [34]
described ‘impact’ within a table, while the reflections of
the researchers on the process of involvement were dis-
cussed by others [35, 37, 40, 52].
Discussion
Key findings: evidence-base relating to stakeholder
involvement in systematic reviews
We identified 291 papers describing stakeholder involve-
ment in systematic reviews. Approximately two thirds of
published examples describe UK activities, but we found
examples from at least 24 countries. Reporting of who
was involved, in what ways and at what stage in the re-
view process was generally very poor, and the majority
of the papers (59%) were judged to provide few details
and/or an inadequate description of the method or ap-
proach of involving stakeholders. Thirty percent of sys-
tematic review teams clearly involved patients/carers,
but in many cases (41%), the stakeholders involved
health professionals, academic experts or representatives
of patient organisations, but not patients or their family
members.
We identified 30 papers, describing 32 systematic re-
views, which we judged to have sufficiently comprehen-
sive reporting to allow a more in-depth synthesis of
methods or approaches to the involvement of stake-
holders in systematic review. We have described key fea-
tures of how stakeholders have been involved in
systematic reviews, using data from these 32 examples.
However, it was notable that, despite the selection of
systematic reviews which were judged to provide a com-
prehensive description of one or more method of in-
volvement, there was still inadequate (or absence of )
reporting of a number of features in which we were in-
terested. For example, the majority of papers did not
provide any information relating to ethical approval or
financial compensation to the stakeholders involved. A
key contributing factor to the poor reporting relating to
aspects of how stakeholders were involved may have
been the lack of a tool or standardised method for
reporting. On the few occasions where a particular tool
has been used to support reporting of information relat-
ing to involvement, the tool has often been developed
specifically by the systematic review authors. In many
cases, the method of reporting comprises a written de-
scription of the activities in which stakeholders have
been involved, but we found inconsistencies in the type
of information presented and the location of this infor-
mation within published papers.
Implications: methods of involving stakeholders in
systematic reviews
The evidence which we have synthesised demonstrates
that actively involving stakeholders within systematic re-
views is feasible, and can be incorporated into a wide
range of different types of systematic review. While there
can be considerable variation in how stakeholders are in-
volved, and the types of stakeholders who are involved,
and there is currently an absence of evidence to directly
inform choices for methods of stakeholder involvement
within future reviews, a number of implications can be
drawn from our synthesised evidence. In particular, evi-
dence drawn from the 32 examples explored in this re-
view can highlight some of the methodological decisions
which may be made when planning stakeholder involve-
ment in future reviews. These include:
 Will people directly affected by the healthcare topic
addressed within the systematic review (i.e.
individual patients, carers or family members) be
involved? Will health professionals, academic
experts or representatives from patient organisations
be involved?
 How to find people to involve? Within our 32
examples, we found two key methods of recruiting
stakeholders to be in systematic reviews; in the
majority of our examples, there were personal
invitations to known individuals or groups, but in
some cases, recruitment occurred through
advertising to the general population in order to get
stakeholders to volunteer to be involved.
 How will people be involved? Within our 32
examples, two distinct methods of involving people
in a systematic review were identified: (i) face-to-
face meetings or events or (ii) electronic Delphi
method. Where there were face-to-face meetings,
these could be attended by invited participants only
or could be an open event or workshop to which
members of the public are invited to attend. Invited
participants may only attend a small number (often
between 1 and 4) of meetings during the course of a
systematic review, but this may be much more
where a participatory approach is used.
 How many stakeholders to involve? The current
evidence base indicates that the number of
stakeholders depends on the way in which they will
be involved. Evidence from the 291 papers in our
synthesis shows that 1 stakeholder may be a co-
author on a systematic review, 2–10 stakeholders
may be members of a steering group, 5–50 stake-
holders may attend face-to-face meetings or focus
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groups and 20–400 stakeholders may participate in
Delphi rounds or attend events or conferences.
 Use of research methods? Our examples highlighted
that the following research methods have sometimes
been incorporated into stakeholder involvement in
systematic reviews: focus groups, interviews and a
number of consensus decision-making techniques
such as Delphi, Nominal Group Technique and vot-
ing/ranking processes.
Other issues to consider when planning stakeholder in-
volvement in systematic reviews are whether ethical ap-
proval will be required and resources for payment of
expenses and any other financial compensation or reward.
Although there is insufficient evidence to directly in-
form choices relating to who to involve and in what way,
the findings arising from the 32 papers identified in this
review have been used to produce, in collaboration with
Cochrane Training, freely available online learning mater-
ial and resources [60]. There have been many urgent calls
for high-quality training materials, reporting guidelines
and examples of best practice to support active stake-
holder involvement and to enhance the relevance, useful-
ness and accessibility of systematic reviews [2, 16, 18, 33,
61]; the evidence from this review therefore can arguably
currently play a key role in learning and support relating
to active stakeholder involvement in systematic reviews.
Implications: reporting stakeholder involvement in
systematic reviews
Recording and reporting of stakeholder involvement is
important, both to ensure transparency in relation to the
contributions and roles of different stakeholders within
the review process and to contribute to the evidence
base relating to this field. This scoping review highlights
that the current reporting of involvement in systematic
reviews is very poor and sometimes absent, and rarely
provides a comprehensive description of who was in-
volved and in what way. While there are a number of
tools and frameworks which review authors could con-
sider using (e.g. [36, 46, 55]), there is not currently any
tool, guidance or recommendations specifically designed
to support reporting of involvement within systematic
reviews. Generic guidance relating to the reporting of
stakeholder involvement in research has recently been
updated (GRIPP2, [62]); however, this guidance has not
been specifically tested for use with systematic reviews
and has lacked international input during development.
It is clear that there is an urgent need for improved
reporting of involvement of stakeholders in systematic
reviews. Such reporting should enhance the ability to de-
velop evidence-based guidance around how to involve
stakeholders in systematic reviews, and to explore and
evaluate the impact of involvement.
Limitations
Identification of relevant systematic reviews and data
extraction
It is unlikely we identified all relevant examples of stake-
holder involvement in systematic reviews, as we adopted a
pragmatic search approach aimed at efficiency within project
time and resource constraints. This was compounded by
poor reporting and inconsistent terminology in this area. We
believe it is highly likely that there are many systematic re-
views where stakeholders played a key role that our methods
could not identify. Our decision to exclude titles without ab-
stracts and review protocols at the study selection stage may
have introduced publication bias into our results, with a bias
toward inclusion of papers published in peer-reviewed jour-
nals. Only one review author extracted data from the in-
cluded studies, and there is the potential that this may have
introduced bias and errors in extraction. In an attempt to
improve transparency and reduce data extraction errors, we
copied and pasted data verbatim from included papers into
an electronic data extraction sheet. This is reported in the
table of included studies (Additional file 7).
Judgement to identify those with most comprehensive
description
The agreement between independent reviewers when
applying the ‘comprehensiveness’ judgement to a subset
of papers indicated that there were disagreements on
around 17% of ‘green’ categorisations. We did not have
the time or resources to have independent judgement on
a higher proportion of studies. We are therefore not
confident that our subset includes all papers which may
provide an adequate description of some parts of the
methods of involving people in a review. However, as
the aim of this phase was to identify and describe
methods of involvement from examples of systematic re-
views, the impact of potentially falsely including or ex-
cluding a paper from this subset was perceived to be
low. We present the included ‘green’ papers as examples
of systematic reviews in which there was involvement of
stakeholders and take care to stress that these are exam-
ples rather than a comprehensive sample.
Our judgement of the comprehensiveness of the de-
scription of the methods was not a judgement of the
quality of the involvement methods and only relates to
the depth of the description of stakeholder involvement
provided in the identified paper. Over half (54%) of the
291 included papers were reports of a guideline or rec-
ommendation, but only 2 of these were judged as ‘green’
for comprehensiveness of description. A potential ex-
planation for this finding could be that stakeholder in-
volvement is generally a core component of guideline
development, but the primary focus of related journal
publications is often the key clinical messages and impli-
cations, rather than the methods of the guideline, which
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are often fully described elsewhere. A judgement of
‘amber’ or ‘red’ for the comprehensiveness of the de-
scription of the method of involvement in the published
paper is not an indication either that the quality of the
methods was poor or that details of methods of stake-
holder involvement are not available elsewhere.
Conclusion
This systematic review summarises evidence relating to
the involvement of stakeholders in systematic reviews. We
identified a relatively large number (291) of papers report-
ing stakeholder involvement in systematic reviews, but the
quality of reporting was generally very poor. The level of
reporting of involvement of stakeholders in systematic re-
views, and the inconsistencies in which this is reported,
must be improved so that guidance around how people
can be involved in systematic reviews can be developed
and the impact of involvement explored. This scoping re-
view lends support to calls for high-quality training mate-
rials and examples of best practice to support active
patient and public involvement and enhance the rele-
vance, usefulness and accessibility of systematic reviews
[2, 16, 18, 61, 63]. We identified a subset of 30 papers
which we judged to provide a comprehensive description
of stakeholder involvement in systematic reviews, and
used these examples to summarise different ways in which
stakeholders have been involved in systematic reviews.
These examples arguably currently provide the best avail-
able information to inform and guide decisions around
the planning of stakeholder involvement within future sys-
tematic reviews. This evidence has been used by Cochrane
Training to develop online learning resources relating to
how to involve people in systematic reviews [60], and has
been used to develop a framework for describing stake-
holder involvement in systematic reviews (Pollock A,
Campbell P, Struthers C, Synnot A, Nunn J, Hill S, Good-
are H, Morris J, Watts C, Morley R: Development and ap-
plication of a framework to describe how stakeholders
have been involved in systematic reviews, submitted).
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